Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07550582
What this trial is testing

Mesenteric Vascular Preconditioning Combined With Laparoscopic and Endoscopic Cooperative Surgery for Submucosal Tumor at the Gastroesophageal Junction

Who this might be right for
Submucosal Tumor of Gastrointestinal TractGastrointestinal Stromal Tumor (GIST)
Peking University People's Hospital 40
Testing effectiveness (Phase 2)Study completedNCT04193553
What this trial is testing

Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure

Who this might be right for
Gastro Intestinal Stromal Tumour
Centre Leon Berard 77
Testing effectiveness (Phase 2)Study completedNCT00278876
What this trial is testing

Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit Mutation

Who this might be right for
SarcomaGastrointestinal Stromal Tumors
Asan Medical Center 47
Early research (Phase 1)Study completedNCT01468688
What this trial is testing

A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients

Who this might be right for
3rd Line GIST
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT00500188
What this trial is testing

Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST

Who this might be right for
Gastrointestinal Stromal Tumors
M.D. Anderson Cancer Center 28
Not applicableEnded earlyNCT01054911
What this trial is testing

Evaluation of Patients With Bulky GIST Using Sunitinib

Who this might be right for
Tumor
University of Alabama at Birmingham 5
Early research (Phase 1)Study completedNCT01643278
What this trial is testing

Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Gastrointestinal Stromal TumorStage III Soft Tissue SarcomaStage IV Soft Tissue Sarcoma
National Cancer Institute (NCI) 29
Early research (Phase 1)Study completedNCT00003704
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

Who this might be right for
Cancer
Alliance for Clinical Trials in Oncology 51
Not applicableUnknownNCT02353052
What this trial is testing

Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST

Who this might be right for
Gastrointestinal Stromal Tumor
Shanghai Zhongshan Hospital 900
Not applicableNo Longer AvailableNCT01646593
What this trial is testing

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy

Who this might be right for
Gastrointestinal Stromal Tumors
Bayer
Large-scale testing (Phase 3)Study completedNCT02103322
What this trial is testing

Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions

Who this might be right for
Chronic Myeloid LeukemiaGastrointestinal Stromal Tumor
Amneal Pharmaceuticals, LLC 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT06087263
What this trial is testing

Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.

Who this might be right for
Gastrointestinal Stromal Tumors
M.D. Anderson Cancer Center 3
Not applicableEnded earlyNCT00767234
What this trial is testing

Permission to Collect Blood Over Time for Research

Who this might be right for
Pancreatic CancerGastrointestinal NeoplasmsColon Rectal Cancer Adenocarcinoma+11 more
Stanford University 104
Testing effectiveness (Phase 2)Looking for participantsNCT05493215
What this trial is testing

Imatinib TDM in GIST

Who this might be right for
Gastrointestinal Stromal Tumors
Reema A. Patel 28
Testing effectiveness (Phase 2)Study completedNCT03440515
What this trial is testing

Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor(GIST)
Asan Medical Center 29
Not applicableLooking for participantsNCT01416714
What this trial is testing

Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy

Who this might be right for
Gastric Cancers
University of Chicago 1,000
Not applicableStudy completedNCT03238820
What this trial is testing

Robotic Resection for Patients With Gastric Gastrointestinal Stromal Tumors: a Single-center Study

Who this might be right for
Gastrointestinal Stromal Tumor of Stomach
JIANG Zhi-Wei 50
Testing effectiveness (Phase 2)Study completedNCT01478373
What this trial is testing

Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 39
Testing effectiveness (Phase 2)Ended earlyNCT02232620
What this trial is testing

BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumors
Sumitomo Pharma America, Inc. 2
Next Page